Researchers have examined the benefits of CBD and other cannabinoids for various health conditions including neurological disorders such as Alzheimer’s disease, multiple sclerosis, essential tremor, migraine, epilepsy, and chronic pain. In addition to studying their effectiveness, studies also strive to evaluate efficacy and safety of cannabinoid use for such illnesses. Results show that CBD and other cannabinoids relieve symptoms through a variety of actions including neuroprotection, neuroplasticity, and neuroinflammation.
CB1 and CB2 Receptors
Cannabinoids, such as CBD, interact with two important cannabinoid receptors – CB1 and CB2. CB1 receptors are mainly found in the brain and assist in regulation of neurotransmitters (serotonin and dopamine), while CB2 receptors are found in immune cells and peripheral tissues where they modulate inflammatory responses. Pain, for example, is modified through the complex interplay between cannabinoids, the endocannabinoid system and neurotransmitter release, and spasticity associated with multiple sclerosis is modified through the cross-talk between cannabinoids, CB1 receptors, and neurotransmitter regulation. When cannabinoids interact with CB2 receptors, they create immune modulation and neuroprotection, thereby improving symptoms of many neurological disorders.
Cannabinoids and Neurological Health Benefits
Numerous studies have examined the benefits of cannabinoids, especially CBD, for neurological and neurodegenerative conditions including but not limited to the following:
- Alzheimer’s disease
- Parkinson’s disease
- Huntington’s disease
- Multiple sclerosis
- Drug-resistant epilepsy (Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex)
- Chronic pain
- Fibromyalgia
- Chronic migraine
While cannabinoids do not cure any neurological or neurodegenerative disorder, they’ve been shown to help manage symptoms and improve quality of life. CBD, for instance, has anti-inflammatory effects in the brain which can alleviate symptoms of many neurological conditions. Cannabinoids also protect neurons from damage (neuroprotection) for illnesses like Alzheimer’s and Parkinson’s disease. Frequency and severity of seizures in people with epilepsy have been documented in studies. Cannabinoids can also help regulate mood, anxiety, depression and sleep as well as reduce pain associated with a number of neurological disorders.
Final Thoughts on Cannabinoids in Neurology: A Quick Snapshot
Cannabinoids, including CBD, have been studied for their health benefits for many neurological and neurodegenerative disorders like multiple sclerosis, chronic pain and epilepsy. Through a complex interaction between cannabinoids, cannabinoid receptors and components of the endocannabinoid system, researchers are understanding more how and why they work. Cannabinoids are no cure for these diseases. Yet, they do hold great promise for a novel approach to better managing symptoms and improving quality of life for those diagnosed with neurological conditions.
Reference
- Hakami, A. and Fahad S. Alshehri. 2025. Therapeutic Potential of Cannabinoids in Neurological Conditions: A Systematic Review of Clinical Trials. Frontiers in Pharmacology, 16:1521792.